NCT06690567

Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary Intervention

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 700 (estimated)
• Sponsor: A.O.U. Città della Salute e della Scienza · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The IMMERGE registry is an observational, international multicentric study, including patients underwent IMPELLA implantation in the participating centers both for cardiogenic shock and high-risk PCI. Only IMPELLA CP, 5.0 and 5.5 devices will be included. Consecutive patients with CS and CHIPs implanted with Impella® CP, 5.0 and 5.5 with at least 6 months of follow-up completed will be enrolled in the registry. Baseline clinical and echocardiographic variables, peri-procedural haemodynamic parameters, laboratoristic findings and complications, together with follow-up outcomes data will be recorded in a dedicated database.

Conditions

• Cardiogenic Shock
• PCI Patients
• Mechanical Circulatory Support

Interventions

Type	Name	Description
DEVICE	Impella implantation	To implante Impella

Timeline

• Start date: 2024-10-10
• Primary completion: 2024-12-10
• Completion: 2024-12-10
• First posted: 2024-11-15
• Last updated: 2024-11-15

Locations

1 site across 1 country: Italy